SB 1839

Abstract

Amends the Wholesale Drug Distribution Licensing Act. Makes a technical change to a Section concerning social security numbers on license applications. Senate Committee Amendment No. 1 Deletes reference to: 225 ILCS 120/27 Adds reference to: 225 ILCS 120/15 from Ch. 111, par. 8301-15 225 ILCS 120/28 new 225 ILCS 120/57 225 ILCS 120/200 Replaces everything after the enacting clause. Amends the Wholesale Drug Distribution Licensing Act. Provides that a third-party logistics provider must be licensed as a third-party logistics provider under the Act (rather than licensed as a wholesale distributor and, to be considered part of the normal distribution channel, must also be an authorized distributor of record). Deletes third-party logistics providers from the definition of "wholesale drug distributor". Provides that each facility of a third-party logistics provider located within Illinois shall be licensed by the Department of Financial and Professional Regulation prior to shipping a prescription drug within the borders of Illinois or to a location outside the borders of Illinois. Sets forth requirements for licensure. Makes other changes. Effective immediately. Senate Floor Amendment No. 2 Deletes reference to: 225 ILCS 120/28 new 225 ILCS 120/200 Adds reference to: 225 ILCS 120/20 from Ch. 111, par. 8301-20 225 ILCS 120/25.5 new 225 ILCS 120/26 225 ILCS 120/30 from Ch. 111, par. 8301-30 225 ILCS 120/35 from Ch. 111, par. 8301-35 225 ILCS 120/40 from Ch. 111, par. 8301-40 225 ILCS 120/80 from Ch. 111, par. 8301-80 225 ILCS 120/155 from Ch. 111, par. 8301-155 Replaces everything after the enacting clause. Amends the Pharmacy Practice Act. In provisions exempting from the Act the sale or distribution of dialysate or devices necessary to perform home peritoneal renal dialysis for patients with end-stage renal disease, provides that an agent of the manufacturer who lawfully holds the dialysate or devices may be registered as a manufacturer, third-party logistics provider, or wholesaler (rather than a manufacturer or wholesaler). Amends the Wholesale Drug Distribution Licensing Act. Requires that each resident third-party logistics provider must be licensed by the Department of Financial and Professional Regulation, and every non-resident third-party logistics provider must be licensed in this State, in accordance with the Act, prior to shipping a prescription drug into this State (and removes language requiring a third-party logistics provider to be licensed as a wholesale distributor and, in order to be considered part of the normal distribution channel, to be an authorized distributor of record). Provides that each third-party logistics provider must designate an individual representative who shall serve as the contact person for the Department, and requires the individual representative to provide the Department with certain information. Prohibits a third-party logistics provider from operating from a place of residence, and requires a third-party logistics provider facility to be located apart and separate from any retail pharmacy licensed by the Department. Provides that the Department may not issue a third-party logistics provider license to an applicant, unless the Department first: ensures that a physical inspection of the facility satisfactory to the Department has occurred at the address provided by the applicant; and determines that the designated representative meets specified qualifications. Requires a third-party logistics provider to publicly display all licenses and have the most recent state and federal inspection reports readily available. Makes conforming changes throughout the Act. Provides that an application (rather than application blanks) for renewal of a license shall be mailed or emailed (rather than mailed) to each licensee at least 60 days before the license expires. Effective immediately.